Kafle S K, Malla S M, Lekhak B D
Om Nursing Home, Katmandu, Nepal.
Can J Anaesth. 1994 Nov;41(11):1091-3. doi: 10.1007/BF03015660.
The purpose of this study was to demonstrate the efficacy of oral ephedrine in preventing hypotension following subarachnoid block. Two hundred women, ASA physical status I or II, undergoing lower abdominal surgery were randomly divided into two groups (n = 100 each). All patients were given routine oral premedication consisting of diazepam 10 mg and ranitidine 150 mg at bed time and at 90 min before surgery. In addition, Group I patients received ephedrine 30 mg, orally, 30 min before subarachnoid block was administered. Group II received only routine premedication. After starting an iv line and preloading with 10 ml.kg-1 crystalloid, patients were given 0.5% heavy bupivacaine 3.2 to 3.6 ml, depending on body weight, intrathecally. Patients with decreases in blood pressure of 20% were given ephedrine i.v., in increments, in addition to crystalloids. Despite a similar level of block (T3-T4) and i.v. fluids, the total dose of ephedrine supplement in Group I was 4.3 +/- 4.8 mg compared with 11.6 +/- 9.4 mg in Group II (P < 0.01). Also, 55 patients in Group I required intraoperative inotrope supplement compared with 83 in Group II (P < 0.01). We conclude that oral ephedrine premedication is a simple and effective way of reducing the incidence of hypotension in patients undergoing lower abdominal surgery under subarachnoid block.
本研究的目的是证明口服麻黄碱在预防蛛网膜下腔阻滞术后低血压方面的疗效。200例拟行下腹部手术、ASA身体状况为I或II级的女性患者被随机分为两组(每组n = 100)。所有患者在睡前及手术前90分钟常规口服地西泮10毫克和雷尼替丁150毫克进行术前用药。此外,I组患者在蛛网膜下腔阻滞给药前30分钟口服30毫克麻黄碱。II组仅接受常规术前用药。建立静脉通路并预充10 ml.kg-1晶体液后,根据体重给患者鞘内注射0.5%重比重布比卡因3.2至3.6毫升。血压下降20%的患者除给予晶体液外,还递增静脉注射麻黄碱。尽管两组的阻滞平面(T3-T4)和静脉输液量相似,但I组麻黄碱补充剂的总剂量为4.3±4.8毫克,而II组为11.6±9.4毫克(P < 0.01)。此外,I组有55例患者术中需要补充血管活性药物,而II组为83例(P < 0.01)。我们得出结论,口服麻黄碱进行术前用药是降低蛛网膜下腔阻滞下接受下腹部手术患者低血压发生率的一种简单有效的方法。